PharmaBoardroom

Sangrae Cho – CEO, Gencurix

Gencurix was the first Asian company to develop a prognostic diagnostic test for breast cancer. Its CEO, Dr Sangrae Cho, discusses the importance of…

Yeul-Hong Kim – Director, K-MASTER, South Korea

Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data for Korean oncology professionals.…

Exploring New & Repurposed Tools in the Fight Against…

Dr Sophia Ononye-Onyia explains why a combination of both repurposed drugs and emerging technologies like 3D bioprinting and artificial intelligence…

US Generics: Company Culture Key to Attracting Talent

Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate…

Top 5 RNA-Based Biopharma Companies

Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA interference (RNAi) is a natural…

SCM Lifescience: A Global Approach to Korean Regenerative…

Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in several global M&A deals in…

Jisoo Pae – CEO, Genome & Company

Genome & Company, with a market cap of USD 280 million, is the highest valued microbiome company worldwide. Dr Jisoo Pae, its co-founder and CEO,…

Korean Corestem Targets US Market for Ground-Breaking ALS…

After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea, Corestem has its sights set on the…

Yan Tan – CEO, Xbiome, China

Yan Tan, CEO of Xbiome, the first AI-based microbiome drug development company in China, outlines the rationale behind the firm’s founding, what…

Kyung Suk Kim – CEO, Corestem

Kyung Suk Kim, CEO of Corestem, the first company to receive approval for a stem cell therapy for Amyotrophic Lateral Sclerosis (ALS) in Korea,…

Latin America Pharma News Roundup June 2020

In recent pharma news from around Latin America, countries are beginning to manufacture their own tests and equipment for dealing with the COVID-19…

China Biotech News Roundup June 15th 2020

A roundup of the latest news from Chinese biotechs, including a bumper IPO for Legend Biotech, a USD two million tie-up between Roche and Innovent…

Tagged with GEN